Xi'an, China

Zheng Zhang

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 6.5

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2012-2025

where 'Filed Patents' based on already Granted Patents

3 patents (USPTO):

Title: Zheng Zhang: Innovator in Antibody Development

Introduction

Zheng Zhang is a prominent inventor based in Xi'an, China. He has made significant contributions to the field of biotechnology, particularly in the development of humanized antibodies. With a total of 3 patents, his work focuses on innovative solutions for medical applications.

Latest Patents

Zheng Zhang's latest patents include groundbreaking research on humanized anti-BASIGIN antibodies. This patent provides a humanized anti-BASIGIN antibody or antigen binding fragment, which includes a heavy chain variable region with a specific amino acid sequence. Additionally, it outlines a composition that comprises the humanized antibody, an isolated nucleic acid sequence encoding it, a vector, and a host cell. Another notable patent is for a human-mouse chimeric anti-CD147 antibody with non-fucosylated glycosylation. This patent details a nucleotide sequence and an antibody that binds to the extracellular region of human CD147, which is crucial for treating CD147 expression-related diseases.

Career Highlights

Zheng Zhang has worked at the Fourth Military Medical University, where he has contributed to various research projects. His expertise in antibody development has positioned him as a key figure in the biotechnology sector.

Collaborations

Zheng has collaborated with notable individuals such as Zhinan Chen and Yang Zhang, enhancing his research and development efforts in the field.

Conclusion

Zheng Zhang's innovative work in antibody development showcases his commitment to advancing medical science. His patents reflect a deep understanding of biotechnology and its potential to address critical health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…